Oncotarget

Interview with Dr. Balraj Singh from the Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center

Dr. Balraj Singh from the Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, describes a recent research paper he co-authored that was published by Oncotarget, entitled, "Inhibition of resistant triple-negative breast cancer cells with low-dose 6-mercaptopurine and 5-azacitidine."

DOI - https://doi.org/10.18632/oncotarget.27922

Full text - https://www.oncotarget.com/article/27922/text/

Correspondence to - Anthony Lucci - alucci@mdanderson.org, and Balraj Singh - bsingh@mdanderson.org

Keywords - resistant TNBC, minimal residual disease, intratumor heterogeneity, breast cancer relapse, metastasis prevention

Oncotarget Scientific Integrity Banner


Copyright © 2022 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC